Huerta and Bain Selected to Serve on NISS Board

The National Institute of Statistical Sciences (NISS), a nonprofit institution that conducts statistical science research, announced that ASA members Gabriel Huerta and Ray Bain were selected to serve on the organization’s board of trustees. The new board members began their terms July 1 and will serve a three-year term.

Huerta is professor of statistics and graduate chair of the department of mathematics and statistics at the University of New Mexico (UNM). He has been with UNM since 2002. Earning his PhD from Duke University in 1998, Huerta’s areas of research include Bayesian time series, space-time modeling, parameter estimation in climate modeling, and extreme value analysis. He is an associate editor for Bayesian Analysis and The American Statistician. He also served as treasurer for the International Society for Bayesian Analysis (ISBA) from 2008–2010 and is currently serving as secretary of ISBA’s Environmental Sciences Section. Huerta was a visiting fellow at the Statistical and Applied Mathematical Sciences Institute in 2009.

Bain is vice president and head of the biostatistics and research decision sciences (BARDS) global clinical development for Merck Research Laboratories (MRL). Prior to joining Merck, he was a member of the biostatistics center at The George Washing¬ton University (1986–1999), where he was co-director of the center and research professor of statistics. Bain earned his PhD from the department of statistics and biometry at Emory University School of Medicine in 1981. From 1981 to 1986, he was an assistant professor of biometry, medicine, and community health at Emory University and a member of the Georgia Center for Cancer Statis¬tics, a site of the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute. Bain has served on the board of directors of the Society for Clinical Trials (2003–2007) and was named Fellow of the society in 2013. He also has served on advisory boards for the department of statistics of George Mason University (2006–2012) and the National Institute of Child Health and Human Development-NIH–sponsored clinical trial research network (2006–2014).